The novel immune landscape of immune‐checkpoint blockade in EBV‐associated malignancies

The Epstein–Barr virus (EBV) is a ubiquitous gamma‐herpesvirus and a class 1 carcinogen that is closely associated with a series of malignant lymphomas and epithelial cell carcinomas. Although these EBV‐related cancers may exhibit different features in clinical symptoms and anatomical sites, they al...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2024-11, Vol.38 (21), p.e70139-n/a
Main Authors: Zhang, Feng, Li, Wenjing, Zheng, Xinglong, Ren, Yinlong, Li, Lijun, Yin, Haiyan
Format: Article
Language:English
Subjects:
Animals
EBV‐associated malignancies
Epstein-Barr Virus Infections - immunology
Epstein-Barr Virus Infections - virology
Epstein–Barr virus
Herpesvirus 4, Human - immunology
Humans
Immune Checkpoint Inhibitors - pharmacology
Immune Checkpoint Inhibitors - therapeutic use
immune‐checkpoint
inhibitory receptors
Lymphocytes, Tumor-Infiltrating - immunology
Neoplasms - immunology
Neoplasms - virology
tumor immune microenvironment
Tumor Microenvironment - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!